SEI Investments’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$789K Buy
162,062
+148,110
+1,062% +$854K ﹤0.01% 2420
2026
Q2
$95K Sell
13,952
-37,520
-73% -$222K ﹤0.01% 3192
2026
Q1
$230K Buy
51,472
+3,614
+8% +$16.8K ﹤0.01% 2921
2025
Q4
$263K Buy
+47,858
New +$232K ﹤0.01% 2795
2024
Q4
– Sell
-39,188
Closed -$78.8K – 2797
2024
Q3
$78.8K Buy
+39,188
New +$86K ﹤0.01% 2592

Other funds holding TSHA

SEI Investments's TSHA Position: Q3 2026 in Review

SEI Investments increased its Taysha Gene Therapies (TSHA) stake by 1,062% in Q3 2026, buying an estimated $854K and bringing the position to 162,062 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

SEI Investments first reported a position in TSHA in Q3 2024 and has held it in 5 quarters since. 205 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.

  • SEI Investments held 162,062 shares of Taysha Gene Therapies worth $789K as of Q3 2026.
  • SEI Investments bought 148,110 Taysha Gene Therapies shares in Q3 2026, an estimated $854K.
  • Taysha Gene Therapies made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2420 holding.
  • SEI Investments first reported a position in Taysha Gene Therapies in Q3 2024 and has held it in 5 quarters since.
  • 205 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.